Close menu




April 8th, 2021 | 13:10 CEST

Aurelius, Deutsche Rohstoff, Mutares - Lighthouses

  • Investments
Photo credits: pixabay.com

What do lighthouses have to do with investment decisions? Seafarers have always used lighthouses to determine their position to avoid dangers and shoals, among other things. Historians name the Egyptian Pharos of Alexandria as the oldest lighthouse in the world. If one transfers the important orientation function to investment decisions, renowned investors can represent these lighthouses. In the following, we present three companies that have repeatedly demonstrated a good nose as holding or investment companies.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: DE000A0JK2A8 , DE000A0XYG76 , DE000A2NB650

Table of contents:


    AURELIUS EQUITY OPPORTUNITIES - 3 acquisitions in a few weeks

    The Aurelius share has continued its upward trend in recent weeks. The shares are currently trading at an annual high of around EUR 29, bringing the Company's total market capitalization to around EUR 870 million. The Munich-based Company took advantage of the low share prices in recent months to buy back its shares (3.16% of the capital stock).

    At the beginning of March, CEO Matthias Täubl informed the capital market that he expected significantly more transactions in 2021 than in the previous year and that he intended to announce a completion in Q1. No sooner said than done - a few days later, the acquisition of HÜPPE GmbH, a leading European supplier of bathroom fittings, which generated sales of EUR 70 million in 2020, was announced. The acquisition of AutoRestore Limited, the leading provider of mobile accident repair services in the UK, followed in early April. In addition, BPG Building Partners Group GmbH, a subsidiary of Aurelius, announced the acquisition of GSB Gerüstbau Bobenheim-Roxheim GmbH with sales of EUR 8 million as an add-on acquisition.

    Given this good corporate news series, it is therefore no wonder that the share price has risen in recent weeks. By way of comparison, Aurelius completed only 6 acquisitions in the whole of last year. In the current financial year, Aurelius intends to distribute EUR 1 per share to shareholders. In each of the two subsequent years, the distribution is to increase by EUR 0.25.

    DEUTSCHE ROHSTOFF - Good year ahead

    Deutsche Rohstoff AG identifies, develops and sells attractive raw material deposits in North America, Australia and Europe. For some time now, the development of oil and gas deposits in the USA has been the main focus of business activities. Often underestimated are the mining projects and investments that the Group holds in its portfolio. Acting opportunistically, Deutsche Rohstoff has proven good timing in the past when selling gold projects and US oil projects.

    The Mannheim-based Company has once again demonstrated its good instinct. In mid-March, the Company announced that it had realized a profit of EUR 8.2 million on its investment portfolio in Q1. In the course of the Covid pandemic, Deutsche Rohstoff had built up a portfolio of shares and bonds in oil and gold stocks and has now partially sold this. In addition, there are still unrealized gains of EUR 3.8 million.

    Furthermore, the Company reported a high increase in the oil portfolio's value to USD 211.6 million. As of December 31, 2020, this figure was only USD 128.8 million due to the significantly lower prices. Given this encouraging news, shareholders should quickly forget about the poor 2020 numbers, which were colored red again. 2021 will be a good year for shareholders of the Company. In addition to the oil sector and the investment portfolio, the subsidiary Almonty, which is preparing to become a major producer of tungsten, is particularly exciting.

    MUTARES - Dividend of 7% beckons in May

    Mutares acquires low-earning companies or parts of companies that are no longer part of a group's core business and are therefore being spun off or where a sale makes sense in the course of corporate succession. European companies with sales of EUR 50 million to EUR 500 million are on the shopping list. These companies should have a high development potential, an established business model and a well-known brand. The focus sectors are Automotive & Mobility, Engineering & Technology and Goods & Services.

    The approach pursued by Mutares is long-term. Successful restructuring is only the first step. As an active investment manager, growth opportunities are constantly evaluated, including add-on acquisitions as part of a focused buy and build strategy. The investment strategy is characteristic of a private equity company and focused on the resale of the acquired medium-sized companies. The performance bar is set very high. Mutares aims to earn 7 to 10 times the invested capital upon exit. Because the management board also holds a significant stake in the Company and thus interests are aligned, investors can assume that no excessive risks are taken to achieve the return targets.

    According to preliminary figures, consolidated annual sales of around EUR 1.6 billion were achieved in fiscal 2020 with over 12,000 employees worldwide in the Group. This figure is expected to almost double by 2023 (EUR 3.0 billion). Mutares allows shareholders to participate in its success in the form of dividends. The dividend consists of a permanent component (EUR 1) and a performance dividend. In May, the Company will distribute a total dividend of EUR 1.50. At a current share price of just under EUR 22, this corresponds to a yield of almost 7%. With a market capitalization of around EUR 340 million, the Company is favorably valued. Investors should add the stock to their portfolios as a good investment.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read